ARCHIVES

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 17 | April 29, 1994

Download PDF Visit The Full Archive

Related Articles

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

NCI’s Problems With FDA Appear To Be Resolved With Agreement on Drug Distribution System

August 26, 1977

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995